Clinical Trials Logo

Clinical Trial Summary

The main purpose of the study is to determine risk factors of poor bowel cleansing in patients referred for colon capsule endoscopy (CCE) examination. Patients will be prepared with polyethylene glycol (PEG), and a booster by using oral low volume sodium phosphate (NaP) and sodium-amidotrizoate and meglumine-amidotrizoate (Gastrografin ®) The investigators also will try to design a predictive score of poor bowel cleansing and to validate the Bowel cleansing score designed by Leighton and modified by Spada


Clinical Trial Description

As in conventional colonoscopy, colon cleansing is essential to achieve a quality examination through the colon capsule endoscopy. The CCE also presents additional difficulties due to the inability to distend the walls of the colon, aspirate liquid and debris and wash. These reasons make that the colonic preparation should be even more effective when the exploration is going to be performed by CCE than with the conventional colonoscopy. Using a combination of PEG, sodium phosphate and bysacodil suppository achieves at least 80% of well-prepared CCE. The rate of CCE with inadequate preparation according to different studies ranges from 12% to 34% . It has recently been suggested that the addition of a water-soluble contrast agent such as Gastrografin® commonly used in different radiological tests could improve cleaning.

Although, predictive factors of poor bowel cleansing in outpatient conventional colonoscopy are well-known, currently, there are no studies that evaluate the independent predictive factors of poor colonic preparation in patients who undergo a CCE. The investigation of the predictive factors of poor colonic preparation in these patients, following the current recommendations can be of great interest to identify those patients with greater difficulties in obtaining an acceptable cleaning quality.

The researchers will offer to participate in the study to patients scheduled for CCE who meet all the inclusion criteria and none of the exclusion criteria. The researchers will explain the purpose of the study and will ask to sign the informed consent. They will give verbal and written information on the diet and the bowel cleansing solution to be taken. The bowel cleansing quality following Spada Bowel Preparation Scale will be assessed by the endoscopist The aim of this study is to figure out the risk factors of bowel cleansing of inadequate bowel preparation in patients referred for colon capsule endoscopy.

A maximum of 8 variables in the multivariate analysis will be included. Considering a percentage of poor preparation of 20%, the inclusion of 350 patients will be necessary. A maximum of 15% of losses will be considered, so the final sample size will be 403 patients.

A univariate and multivariate analysis will be carried out to determine those factors associated with a lack of progression from capsule to rectum and accelerated progression. For the first of these objectives, well prepared colonoscopies but in which the rectum was not identified (identification of the hemorrhoidal plexus) will be excluded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03933371
Study type Observational
Source Hospital Universitario de Canarias
Contact Antonio Z Gimeno García, MD, PhD
Phone 34-922678000
Email antozeben@gmail.com
Status Not yet recruiting
Phase
Start date May 2019
Completion date December 2020

See also
  Status Clinical Trial Phase
Terminated NCT04555135 - A Clinical Study To Measure The Effect Of Use Of Artificial Intelligence (AI) Enabled Computer Aided Detection (CADe) Assistance Software In Detecting Colon Polyps During Standard Colonoscopy Procedures N/A
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Completed NCT03551379 - A Double Balloon Endoscopic Platform for ESD
Completed NCT03619122 - Second Forward View Examination of Proximal Colon on Adenoma Detection Rate N/A
Completed NCT03742232 - Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen. Phase 4
Completed NCT03336359 - Linked Color Imaging Versus Narrow Band Imaging for Colorectal Adenoma Detection N/A
Recruiting NCT01952418 - Effect of Video Monitor Size on Adenoma Detection Rate N/A
Recruiting NCT01719198 - Usefulness of Calprotectin for Colon Adenoma Screening N/A
Completed NCT03444090 - Impacts of Inspection During Instrument Insertion on Colonoscopy Quality N/A
Completed NCT03690297 - Linked Color Imaging (LCI) for Colorectal Adenoma Detection N/A
Completed NCT03696992 - BLI, NBI or White Light Colonoscopy for Proximal Colonic Adenoma N/A
Not yet recruiting NCT03679429 - NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum
Completed NCT02819492 - Side Specific Withdrawal Times for Colonoscopy: Impact on Adenoma Detection in the Proximal and Distal Colon N/A
Recruiting NCT01992406 - Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection N/A
Recruiting NCT04138030 - Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial N/A
Recruiting NCT06063720 - Effective Withdrawal Time and Adenoma Detection Rate
Not yet recruiting NCT05041478 - Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC) N/A
Completed NCT02980562 - Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl Phase 3
Recruiting NCT05448300 - Adenoma Detection Rate in Water and Air Colonoscopy Using Computer-aided System N/A
Completed NCT03501849 - Cold Snare Polypectomy N/A